Four of the nine operational medical cannabis companies in New Jersey could soon begin delivering marijuana to patients, finally heeding the calls of patients to ease access to their medicine.
The four companies confirmed to NJ Cannabis Insider that they are seriously developing plans or awaiting approval of their delivery plans from the state Department of Health, which late last month enacted a waiver that allows for the delivery of medical cannabis.
Home delivery became possible with the passage of Jake Honig’s Law last summer, which expanded access and upped marijuana purchase limits for patients. As some immunocompromised patients worried about waiting in lines at dispensaries during the coronavirus outbreak, pushes for delivery got new life.
While the waiver marks a step forward, it will take time before delivery can become a quick and convenient solution, both due to the lack of dispensaries in the state and potential kinks in the system.
But Rise Paterson filed its delivery plan with the health department Monday, said Devra Karlebach, the CEO of GTI New Jersey.